Patient Guide: Safety first: should the high tolerability of intramuscular anti-spike COVID-19 monoclonal antibody change our expectations of vaccine safety?

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04859517
Status: COMPLETED_NEXT_PHASE_UPCOMING
Condition: COVID-19
Phase: PHASE2, PHASE3

Loading interactive enrollment tools...

The full interactive experience will load momentarily